Local Tech Wire

DURHAM, N.C. – Life sciences research and services firm is expanding in size and expertise, having acquired Ohio-based Prologue Research International.

Prologue is a contract research organization focused on research in oncology.

Financial terms were not disclosed.

Novella Clinical was formerly known as PharmaLinkFHI.

"The acquisition of Prologue strengthens our oncology therapeutic franchise and is a strategic addition to our earlier announced deal this year with OSI Pharmaceuticals," said Novella Chief Executive Officer Richard Staub in a statement.

"Prologue’s experience includes the management of more than 120 oncology trials across a wide variety of indications with a customer base that does not overlap with Novella Clinical’s,” he added. “With Prologue, Novella will expand its support to oncology Sponsors with the creation of a dedicated business unit focused exclusively on oncology drug development, with the objective of bringing much needed products to market to improve the lives of people with cancer."

Prologue employs some 60 people. Novella has a staff of 738 people.

Get the latest news alerts: at Twitter.